GlaxoSmithKline Extends Asia Push with $109.5 Million Dong-A Pharmaceutical Co., Ltd. Alliance

May 11, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Business Week -- GlaxoSmithKline PLC says it has signed a strategic alliance with South Korea's Dong-A Pharmaceuticals Co., acquiring a 9.9 percent stake for 73.9 million pounds ($109.5 million).

Twitter
LinkedIn
Facebook
Email
Print

Alliances Asia Europe

GSK